Gilead Sciences Statistics
Total Valuation
Gilead Sciences has a market cap or net worth of GBP 101.91 billion. The enterprise value is 113.75 billion.
Market Cap | 101.91B |
Enterprise Value | 113.75B |
Important Dates
The next estimated earnings date is Friday, August 1, 2025.
Earnings Date | Aug 1, 2025 |
Ex-Dividend Date | Jun 13, 2025 |
Share Statistics
Current Share Class | 1.24B |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.28% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.24B |
Valuation Ratios
The trailing PE ratio is 22.07 and the forward PE ratio is 13.57.
PE Ratio | 22.07 |
Forward PE | 13.57 |
PS Ratio | 4.58 |
PB Ratio | 6.90 |
P/TBV Ratio | n/a |
P/FCF Ratio | 13.38 |
P/OCF Ratio | 12.70 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.18, with an EV/FCF ratio of 14.93.
EV / Earnings | 24.64 |
EV / Sales | 5.40 |
EV / EBITDA | 11.18 |
EV / EBIT | 14.17 |
EV / FCF | 14.93 |
Financial Position
The company has a current ratio of 1.37, with a Debt / Equity ratio of 1.31.
Current Ratio | 1.37 |
Quick Ratio | 1.06 |
Debt / Equity | 1.31 |
Debt / EBITDA | 1.80 |
Debt / FCF | 2.53 |
Interest Coverage | 11.14 |
Financial Efficiency
Return on equity (ROE) is 32.66% and return on invested capital (ROIC) is 15.79%.
Return on Equity (ROE) | 32.66% |
Return on Assets (ROA) | 12.14% |
Return on Invested Capital (ROIC) | 15.79% |
Return on Capital Employed (ROCE) | 24.84% |
Revenue Per Employee | 1.26M |
Profits Per Employee | 262,321 |
Employee Count | 17,600 |
Asset Turnover | 0.51 |
Inventory Turnover | 3.45 |
Taxes
In the past 12 months, Gilead Sciences has paid 665.63 million in taxes.
Income Tax | 665.63M |
Effective Tax Rate | 12.60% |
Stock Price Statistics
The stock price has increased by +67.24% in the last 52 weeks. The beta is 0.31, so Gilead Sciences's price volatility has been lower than the market average.
Beta (5Y) | 0.31 |
52-Week Price Change | +67.24% |
50-Day Moving Average | 107.11 |
200-Day Moving Average | 99.58 |
Relative Strength Index (RSI) | 56.33 |
Average Volume (20 Days) | 7,055 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 2.53 |
Income Statement
In the last 12 months, Gilead Sciences had revenue of GBP 22.24 billion and earned 4.62 billion in profits. Earnings per share was 3.66.
Revenue | 22.24B |
Gross Profit | 17.41B |
Operating Income | 8.48B |
Pretax Income | 5.28B |
Net Income | 4.62B |
EBITDA | 10.62B |
EBIT | 8.48B |
Earnings Per Share (EPS) | 3.66 |
Balance Sheet
The company has 6.74 billion in cash and 19.31 billion in debt, giving a net cash position of -12.57 billion.
Cash & Cash Equivalents | 6.74B |
Total Debt | 19.31B |
Net Cash | -12.57B |
Net Cash Per Share | n/a |
Equity (Book Value) | 14.77B |
Book Value Per Share | 11.91 |
Working Capital | 3.53B |
Cash Flow
In the last 12 months, operating cash flow was 8.02 billion and capital expenditures -404.02 million, giving a free cash flow of 7.62 billion.
Operating Cash Flow | 8.02B |
Capital Expenditures | -404.02M |
Free Cash Flow | 7.62B |
FCF Per Share | n/a |
Margins
Gross margin is 78.29%, with operating and profit margins of 38.11% and 20.76%.
Gross Margin | 78.29% |
Operating Margin | 38.11% |
Pretax Margin | 23.75% |
Profit Margin | 20.76% |
EBITDA Margin | 47.76% |
EBIT Margin | 38.11% |
FCF Margin | 34.26% |
Dividends & Yields
This stock pays an annual dividend of 2.39, which amounts to a dividend yield of 2.15%.
Dividend Per Share | 2.39 |
Dividend Yield | 2.15% |
Dividend Growth (YoY) | -0.58% |
Years of Dividend Growth | 3 |
Payout Ratio | 65.24% |
Buyback Yield | -0.28% |
Shareholder Yield | 1.87% |
Earnings Yield | 4.53% |
FCF Yield | 7.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Gilead Sciences has an Altman Z-Score of 3.19 and a Piotroski F-Score of 7.
Altman Z-Score | 3.19 |
Piotroski F-Score | 7 |